'Plasma products' presentation slideshows

Choosing Appropriate Blood Components and Derivatives

CLS 423 Clinical Immunohematology II. Choosing Appropriate Blood Components and Derivatives. For each case, decide which blood component or derivative would be most appropriate to transfuse. Then select the best product from the available inventory. . Case One.

805 views • 65 slides

FABB - 2013

FABB - 2013. HOT TOPICS Current Issues in Blood Banking Ron Jackson Director, Compliance Branch FDA FLORIDA DISTRICT June 7, 2013. New Labeling Regulations. New Labeling Regulations. Published in Federal Register

719 views • 63 slides

Current Considerations on Plasma for Further Manufacturing Obtained from Whole Blood Donors Alan E. Williams, Ph.D.

Current Considerations on Plasma for Further Manufacturing Obtained from Whole Blood Donors Alan E. Williams, Ph.D. Associate Director for Regulatory Affairs, OBRR, CBER, FDA Blood Products Advisory Committee April 28-29, 2011. 1. Plasma for Further Manufacturing .

494 views • 26 slides

347 views • 21 slides

Self-Sufficiency of Plasma Derivatives

Self-Sufficiency of Plasma Derivatives. Definition. The provision of human blood and plasma products from within a certain population to satisfy the clinical needs of that population. History & Rationale. Council of Europe. Recommendation R (88) 4, March 1988 :

417 views • 16 slides